Login
No login? Register now to unlock hella tokens
No login? Register now to unlock hella tokens
Log In person
Denali Therapeutics Inc logo
Denali Therapeutics Inc DNLI
summarize 1 total product line
calendar_month Revenue as of 12/31/2023
Reporting Segmentarrow_drop_up Product Line Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Pharma for Neurodegenerative Diseases
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
330.53M 100.00%
keyboard_arrow_right keyboard_arrow_down
Pharma for Neurodegenerative Diseases
Pre-Revenue Pharmaceuticals
330.53M 100.00%
keyboard_arrow_right
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.